Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is N/A as of Sunday, August 30, 2026.
EBITDA MARGIN
N/A
PDS Biotechnology Corporation
Market Cap
$11.79M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$438.82M
EBITDA Margin
-48.80%
TTM Avg
-44.09%
3Y Avg
-45.35%
5Y Avg
-45.35%
Market Cap
$1.18B
EBITDA Margin
3.96%
TTM Avg
-13.21%
3Y Avg
-146.19%
5Y Avg
-104.68%
Market Cap
$2.23B
EBITDA Margin
16.41%
TTM Avg
1.22%
3Y Avg
-1.65%
5Y Avg
4.31%
Market Cap
$3.06B
EBITDA Margin
22.42%
TTM Avg
17.70%
3Y Avg
-0.76%
5Y Avg
-37.34%
Market Cap
$5.40B
EBITDA Margin
21.06%
TTM Avg
20.50%
3Y Avg
18.63%
5Y Avg
16.67%
Market Cap
$6.43B
EBITDA Margin
6.82%
TTM Avg
6.08%
3Y Avg
-0.44%
5Y Avg
-8.67%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PDS Biotechnology Corporation (PDSB) | $11.79M | N/A | N/A | N/A | N/A |
| Shoulder Innovations, Inc. (SI)vs › | $438.82M | -48.80% | -44.09% | -45.35% | -45.35% |
| NRC Health (NRC)vs › | $492.43M | 21.99% | 25.40% | 28.98% | 31.97% |
| Teladoc Health, Inc. (TDOC)vs › | $1.18B | 3.96% | -13.21% | -146.19% | -104.68% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.23B | 16.41% | 1.22% | -1.65% | 4.31% |
| TransMedics Group, Inc. (TMDX)vs › | $3.06B | 22.42% | 17.70% | -0.76% | -37.34% |
| Doximity, Inc. (DOCS)vs › | $5.00B | 35.56% | 38.69% | 36.58% | 34.55% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.40B | 21.06% | 20.50% | 18.63% | 16.67% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.43B | 6.82% | 6.08% | -0.44% | -8.67% |
| Chemed Corporation (CHE)vs › | $6.84B | 15.93% | 16.80% | 17.55% | 18.41% |
Gross Margin
0.0%
EBITDA Margin
N/A
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
